Back
Amicus Therapeutics 10K Form
Sell
48
FOLD
Amicus Therapeutics
Last Price:
11.22
Seasonality Move:
-7.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2023-11-08 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2023-08-08 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2023-05-10 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2022-11-07 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2022-08-04 | 10Q | FOLD/Amicus Therapeutics Quarterly |
Receive FOLD News And Ratings
See the #1 stock for the next 7 days that we like better than FOLD
FOLD Financial Statistics
Sales & Book Value
| Annual Sales: | $399.36M |
|---|---|
| Cash Flow: | $21.59M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.45 |
| Price / Book: | 24.62 |
Profitability
| EPS (TTM): | -0.39000 |
|---|---|
| Net Income (TTM): | $-119.54M |
| Gross Margin: | $362.03M |
| Return on Equity: | -89.45% |
| Return on Assets: | -15.97% |
Amicus Therapeutics Earnings Forecast
Key Amicus Therapeutics Financial Ratios
- The Gross Profit Margin over the past 21 years for FOLD is 90.65%.
- The Selling, General & Administrative Expenses for FOLD have been equal to 68.93% of Gross Profit Margin.
- The Research & Development expenses have been 38.16% of Revenue.
- The Interest Expense is -33.08% of Operating Income.
- The Net Earning history of FOLD is -37.96% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 11 years.
Amicus Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FOLD |
| CUSIP: | 03152W |
| Website: | amicusrx.com |
Debt
| Debt-to-Equity Ratio: | 2.93 |
|---|---|
| Current Ratio: | 2.75 |
| Quick Ratio: | 2.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 28.2 |
FOLD Technical Analysis vs Fundamental Analysis
Sell
48
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $11.00. The Score for FOLD is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.